Alembic Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹1,633.46Cr |
Net Profits | ₹180.45Cr |
Net Profit Margins | 11.05% |
Highlights
Revenue:
Alembic Pharmaceuticals Ltd’s revenue jumped 8.21% since last year same period to ₹1,633.46Cr in the Q3 2023-2024. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 1.77% jump in its revenue since last 3-months.
Net Profits:
Alembic Pharmaceuticals Ltd’s net profit jumped 48.01% since last year same period to ₹180.45Cr in the Q3 2023-2024. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 32.14% jump in its net profits since last 3-months.
Net Profit Margins:
Alembic Pharmaceuticals Ltd’s net profit margin jumped 36.77% since last year same period to 11.05% in the Q3 2023-2024. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 29.84% jump in its net profit margins since last 3-months.
